98 related articles for article (PubMed ID: 23666221)
1. [Refractory acute myeloid leukemia developed malignancy-associated hemophagocytic lymphohistiocytosis during treatment of invasive fungal infection].
Yamada A; Moritake H; Sawa D; Shimonodan H; Kojima H; Kamimura S; Nunoi H
Rinsho Ketsueki; 2013 Apr; 54(4):383-7. PubMed ID: 23666221
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
[TBL] [Abstract][Full Text] [Related]
3. FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience.
Pastore D; Specchia G; Carluccio P; Liso A; Mestice A; Rizzi R; Greco G; Buquicchio C; Liso V
Ann Hematol; 2003 Apr; 82(4):231-5. PubMed ID: 12707726
[TBL] [Abstract][Full Text] [Related]
4. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
6. Leukemia cells directly phagocytose blood cells in AML-associated hemophagocytic lymphohistiocytosis: a case report and review of the literature.
Hatano K; Nagai T; Matsuyama T; Sakaguchi Y; Fujiwara S; Oh I; Muroi K; Ozawa K
Acta Haematol; 2015; 133(1):98-100. PubMed ID: 25226795
[No Abstract] [Full Text] [Related]
7. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.
Pan H; Feng DN; Song L; Sun LR
BMC Pediatr; 2016 Jul; 16():116. PubMed ID: 27473573
[TBL] [Abstract][Full Text] [Related]
9. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
10. Acute respiratory distress syndrome as an initial presentation of hemophagocytic lymphohistiocytosis after induction therapy for acute myeloid leukemia.
Nishikawa T; Okamoto Y; Tanabe T; Shinkoda Y; Kodama Y; Kakihana Y; Goto M; Kawano Y
Pediatr Hematol Oncol; 2011 Apr; 28(3):244-8. PubMed ID: 21083362
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93].
Creutzig U; Zimmermann M; Reinhardt D; Lehrnbecher T
Klin Padiatr; 2003; 215(3):151-8. PubMed ID: 12778355
[TBL] [Abstract][Full Text] [Related]
12. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.
Delavigne K; Bérard E; Bertoli S; Corre J; Duchayne E; Demur C; Mansat-De Mas V; Borel C; Picard M; Alvarez M; Sarry A; Huguet F; Récher C
Haematologica; 2014 Mar; 99(3):474-80. PubMed ID: 24142998
[TBL] [Abstract][Full Text] [Related]
13. Cytosine arabinoside and mitoxantrone induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia.
Wells RJ; Gold SH; Krill CE; Cornelius AS; Byrd RL; Ruymann FB; Feusner J; White ML; Cairo MS
Leukemia; 1994 Oct; 8(10):1626-30. PubMed ID: 7934157
[TBL] [Abstract][Full Text] [Related]
14. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of mitoxantrone and cytarabine in acute myeloid leukemia.
Brito-Babapulle F; Catovsky D; Slocombe G; Newland AC; Marcus RE; Goldman JM; Galton DA
Cancer Treat Rep; 1987 Feb; 71(2):161-3. PubMed ID: 3467843
[TBL] [Abstract][Full Text] [Related]
16. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
[TBL] [Abstract][Full Text] [Related]
17. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19-associated hemophagocytic lymphohistiocytosis in a child with precursor B-cell acute lymphoblastic leukemia under maintenance chemotherapy.
Matsubara K; Uchida Y; Wada T; Iwata A; Yura K; Kamimura K; Nigami H; Fukaya T
J Pediatr Hematol Oncol; 2011 Oct; 33(7):565-9. PubMed ID: 21617562
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia.
Trifilio SM; Rademaker AW; Newman D; Coyle K; Carlson-Leuer K; Mehta J; Altman J; Frankfurt O; Tallman MS
Leuk Res; 2012 Apr; 36(4):394-6. PubMed ID: 22172465
[TBL] [Abstract][Full Text] [Related]
20. Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
Lee SS; Lee JH; Lee JH; Kim DY; Kim SH; Lim SN; Lee YS; Seol M; Ryu SG; Kang YA; Jang S; Park CJ; Chi HS; Yun SC; Lee KH
Leuk Res; 2009 Apr; 33(4):511-7. PubMed ID: 18819710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]